About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-TS2
A12265G
A12265G-F1
C12224T
C12224T-F1
C12246A
C12258A
C12258A-F2
C12258A-F1
C12262A
C12264T
C12264T-F2
C12264T-F1
G12207A
G12207A-F2
G12236A
G12236A-F1
T12261C
T12261C-F1
Edit by Mitofam Team
-
+
首页
C12258A
# General Information | **Position** | **12258** | **Variant** | **m.12258C\>A** | **Locus** | **MT\-TS2** | **RNA** | **tRNA Ser (AGY)** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **mitoTIP** | Pathogenic | **Pathogenicity** | Cfrm \[LP] | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # Pedigree Information The **m.12258C\>A** variant in MT\-TS2 has been reported in 2 pedigrees. To date, 32 carriers have been reported. Reported mutation loads ranged from 5% to 95%, with a median of 50% overall; affected carriers showed mutation loads from 5% to 95%, with a median of 50%; unaffected carriers showed mutation loads from 20% to 80%, with a median of 40%. In one affected carrier, a marked tissue\-specific difference was observed, with higher mutation loads in muscle (68\.4%) than in blood (19\.4%). The main clinical manifestations among affected carriers included retinitis pigmentosa, progressive sensorineural hearing loss, diabetes, cataracts, deafness, and cerebellar ataxia. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 12258 | m.12258C\>A | [C12258A\-F1](https://mitofam.com/doc/724/) | UK | Diabetes mellitus | ND | ND | 1998 | [9792552](https://pubmed.ncbi.nlm.nih.gov/9792552/) | | | 2 | 12258 | m.12258C\>A | [C12258A\-F2](https://mitofam.com/doc/725/) | Ireland | Retinitis pigmentosa, progressive sensorineural hearing loss | 8 | 23 | 1999 | [10090882](https://pubmed.ncbi.nlm.nih.gov/10090882/) | | # Carrier Information | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 12258 | m.12258C\>A | C12258A\-F1 | C12258A\-F1\-I2 | Uninf | F | Y | Y | A | 61 | 19\.4% | 68\.4% | / | / | Diabetes, cataracts, deafness, cerebellar ataxia | | | 2 | 12258 | m.12258C\>A | C12258A\-F1 | C12258A\-F1\-II1 | Fam | F | N | Y | A | 20 | 45% | 85% | / | / | Diabetes, cataracts, deafness | | | 3 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-I2 | Uninf | F | N | N | D | ND | / | / | / | / | Healthy | | | 4 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-II2 | Fam | F | | Y | D | ND | / | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 5 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-III11 | Fam | M | | Y | A | ND | 5% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 6 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-III13 | Fam | F | | Y | D | ND | / | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 7 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV33 | Fam | F | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 8 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV34 | Fam | M | | Y | A | ND | 30% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 9 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV35 | Fam | F | | Y | A | ND | 40% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 10 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV37 | Fam | F | | N | A | ND | 60% | / | / | / | Healthy | | | 11 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV39 | Fam | M | | N | A | ND | 40% | / | / | / | Healthy | | | 12 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV44 | Fam | F | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 13 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV47 | Fam | F | | Y | A | ND | 30% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 14 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV48 | Fam | F | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 15 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV52 | Fam | F | | Y | A | ND | 10% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 16 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV54 | Fam | F | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 17 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV58 | Fam | F | | Y | A | ND | 40% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 18 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV60 | Fam | M | | Y | A | ND | 20% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 19 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-IV61 | Fam | M | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 20 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V1 | Fam | F | | N | A | ND | 80% | / | / | / | Healthy | | | 21 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V6 | Fam | F | | Y | A | ND | 95% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 22 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V7 | Fam | F | | N | A | ND | 40% | / | / | / | Healthy | | | 23 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V16 | Fam | F | | Y | A | ND | 80% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 24 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V17 | Fam | M | | Y | A | ND | 80% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 25 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V18 | Fam | F | | Y | A | ND | 80% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 26 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V25 | Fam | F | | Y | A | ND | 50% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 27 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V26 | Fam | F | | N | A | ND | 40% | / | / | / | Healthy | | | 28 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V28 | Fam | F | | N | A | ND | 40% | / | / | / | Healthy | | | 29 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V14 | Fam | M | | Y | A | ND | 60% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 30 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V22 | Fam | M | | N | A | ND | 20% | / | / | / | Healthy | | | 31 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V23 | Fam | F | | Y | A | ND | 80% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | | 32 | 12258 | m.12258C\>A | C12258A\-F2 | C12258A\-F2\-V5 | Fam | F | N | Y | A | ND | 80% | / | / | / | Retinitis pigmentosa, progressive sensorineural hearing loss | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoying Chen
2026年6月22日 18:26
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)